Literature DB >> 15188134

Is gliomatosis peritonei derived from the associated ovarian teratoma?

Man-Yee Kwan1, Wouter Kalle, Gene T C Lau, John K C Chan.   

Abstract

Gliomatosis peritonei, a rare condition that occurs almost exclusively in the setting of ovarian immature teratoma, is characterized by the occurrence of nodules of mature glial tissues in the peritoneum. It is controversial whether glial tissues are derived from maturation of the associated teratomatous tissue that has implanted in the peritoneum, or glial differentiation of subperitoneal stem cells. In this study, we employed the unique genetic characteristics of ovarian teratomas (often with a duplicated set of maternal chromosomes and thus homozygous at many polymorphic microsatellite loci) versus normal tissues (heterozygous pattern due to presence of maternal and paternal genetic materials) to investigate the origin of gliomatosis peritonei. DNA samples were extracted from microdissected paraffin-embedded tissues, including the glial implants, the associated ovarian teratomas, and normal tissues, to determine their patterns of microsatellite loci in a multiplex polymerase chain reaction system. Two cases were not informative because the ovarian teratoma showed a heterozygous microsatellite pattern. In the 5 informative cases, the normal tissues showed a heterozygous pattern in the microsatellite loci, the associated teratomas showed a homozygous pattern, and the glial tissues showed a heterozygous pattern. Thus, gliomatosis peritonei is genetically unrelated to the associated teratoma but is probably derived from nonteratomatous cells, such as through metaplasia of submesothelial cells.

Entities:  

Mesh:

Year:  2004        PMID: 15188134     DOI: 10.1016/j.humpath.2004.01.025

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Frequent homozygosity in both mature and immature ovarian teratomas: a shared genetic basis of tumorigenesis.

Authors:  Olivia L Snir; Maura DeJoseph; Serena Wong; Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  Gliomatosis peritonei with bilateral ovarian teratomas: A report of two cases.

Authors:  Jiawei Wang; Jingjing Xu; Minming Zhang; Baizhou Li
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

3.  Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma.

Authors:  Na Ra Yoon; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Insuk Sohn; Chang Ohk Sung; Sang Yong Song
Journal:  Virchows Arch       Date:  2012-07-21       Impact factor: 4.064

4.  One man, one disease?

Authors:  Frankie Wai Tsoi Cheng; K F To; V Lee; M M K Shing; W K Leung; C K Li
Journal:  BMJ Case Rep       Date:  2009-04-28

5.  [Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas].

Authors:  D Schmidt; F Kommoss
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

6.  Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.

Authors:  Li Liang; Yifen Zhang; Anais Malpica; Preetha Ramalingam; Elizabeth D Euscher; Gregory N Fuller; Jinsong Liu
Journal:  Mod Pathol       Date:  2015-11-13       Impact factor: 7.842

7.  Growing teratoma syndrome and peritoneal gliomatosis.

Authors:  H Mrabti; I El Ghissassi; Y Sbitti; M Amrani; H Hachi; H Errihani
Journal:  Case Rep Med       Date:  2011-04-07

8.  Hepatic teratoma and peritoneal gliomatosis: a case report.

Authors:  Christoph Karlo; Sebastian Leschka; Matthias Dettmer; Stefan Breitenstein; Paul Stolzmann
Journal:  Cases J       Date:  2009-12-10

9.  Immature ovarian teratoma with unusual gliomatosis.

Authors:  Ancuta Gheorghisan-Galateanu; Dana Cristina Terzea; Mara Carsote; Catalina Poiana
Journal:  J Ovarian Res       Date:  2013-04-16       Impact factor: 4.234

10.  Huge ovarian mature cystic teratoma with gliomatosis peritonei and massive ascites in a postmenopausal woman.

Authors:  Chia-Shuen Lin; Ci Huang; Pei-Chen Li; Yung-Hsiang Hsu; Dah-Ching Ding
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.